Literature DB >> 10905375

Cardiovascular effects of growth hormone.

W J Brickman1, B L Silverman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10905375     DOI： 10.1385/ENDO:12:2:153

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.925


× No keyword cloud information.
  90 in total

1.  Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction.

Authors:  D Grimm; D Cameron; D P Griese; G A Riegger; E P Kromer
Journal:  Cardiovasc Res       Date:  1998-11       Impact factor: 10.787

2.  Ontogeny of insulin-like growth factor-I and -II gene expression in ovine fetal heart.

Authors:  C Y Cheung; D D Johnson; V Reyes
Journal:  J Soc Gynecol Investig       Date:  1996 Nov-Dec

3.  Cardiovascular aspects in acromegaly: effects of treatment.

Authors:  G Lombardi; A Colao; D Ferone; P Marzullo; M L Landi; S Longobardi; E Iervolino; A Cuocolo; S Fazio; B Merola; L Sacca
Journal:  Metabolism       Date:  1996-08       Impact factor: 8.694

4.  Beneficial effects of growth hormone treatment in GH-deficient adults.

Authors:  J O Jørgensen; S A Pedersen; L Thuesen; J Jørgensen; T Ingemann-Hansen; N E Skakkebaek; J S Christiansen
Journal:  Lancet       Date:  1989-06-03       Impact factor: 79.321

5.  Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction.

Authors:  A Cittadini; J D Grossman; R Napoli; S E Katz; H Strömer; R J Smith; R Clark; J P Morgan; P S Douglas
Journal:  J Am Coll Cardiol       Date:  1997-04       Impact factor: 24.094

6.  Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion.

Authors:  M Buerke; T Murohara; C Skurk; C Nuss; K Tomaselli; A M Lefer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults.

Authors:  J O Johansson; K Landin; L Tengborn; T Rosén; B A Bengtsson
Journal:  Arterioscler Thromb       Date:  1994-03

8.  A preliminary study of growth hormone in the treatment of dilated cardiomyopathy.

Authors:  S Fazio; D Sabatini; B Capaldo; C Vigorito; A Giordano; R Guida; F Pardo; B Biondi; L Saccà
Journal:  N Engl J Med       Date:  1996-03-28       Impact factor: 91.245

9.  Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure.

Authors:  M Y Donath; G Sütsch; X W Yan; B Piva; H P Brunner; Y Glatz; J Zapf; F Follath; E R Froesch; W Kiowski
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

10.  Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle.

Authors:  E A Rodrigues; M P Caruana; A Lahiri; J D Nabarro; H S Jacobs; E B Raftery
Journal:  Br Heart J       Date:  1989-09
View more
  3 in total

1.  Growth hormone deficiency and cardiovascular risk: do we need additional markers?

Authors:  M Gola; A Giustina
Journal:  Endocrine       Date:  2012-10       Impact factor: 3.633

Review 2.  Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse.

Authors:  Edward O List; Lucila Sackmann-Sala; Darlene E Berryman; Kevin Funk; Bruce Kelder; Elahu S Gosney; Shigeru Okada; Juan Ding; Diana Cruz-Topete; John J Kopchick
Journal:  Endocr Rev       Date:  2010-12-01       Impact factor: 19.871

3.  QT dispersion in patients with acromegaly.

Authors:  Mustafa Unubol; Ufuk Eryilmaz; Engin Guney; Mevlut Ture; Cagdas Akgullu
Journal:  Endocrine       Date:  2012-11-13       Impact factor: 3.633
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.